Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine—A Prospective Cohort Study by the AGMT

Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine—A Prospective Cohort Study by the AGMT

In this prospective study (NCT01595295), 272 patients treated with azacitidine completed 1456 EuroQol 5-Dimension (EQ-5D) questionnaires. Linear mixed-effect modelling was used to incorporate longitudinal data. When compared with a matched reference population, myeloid patients reported more pronoun...

Full description

Bibliographic Details
Main Authors: Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonia Vallet, Martin Schreder, Thomas Melchardt, Norbert Stute, Kim Tamara Föhrenbach Quiroz, Michael Leisch, Alexander Egle, Lukas Scagnetti, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Marc Vaisband, Jan Hasenauer, Nadja Zaborsky, Richard Greil, Reinhard Stauder
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
health-related quality of life (HRQoL)
patient-reported outcome (PRO)
EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L)
azacitidine
Austrian Registry of Hypomethylating Agents
prognosis
Online Access:https://www.mdpi.com/2072-6694/15/5/1388

Internet

https://www.mdpi.com/2072-6694/15/5/1388

Similar Items